Physician profile
Claire Sanger Dillingham
NPI 1902006646
$142,083.91
in general payments reported to CMS, 2019-2025
30 companies · $25K in 2025
The $25K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $18K · 2021: $23K · 2022: $27K · 2023: $16K · 2024: $1,163 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $13K · Consulting Fee: $7,345 · Food and Beverage: $3,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,350.00 |
| Travel and Lodging | $13,442.78 |
| Consulting Fee | $7,345.00 |
| Food and Beverage | $3,686.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $63,408.59 | 2020-2024 | Integra, Surgimend, Codman Certas |
| Acell, INC. | $50,379.66 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $21,283.28 | 2022-2025 | |
| Tela Bio, INC. | $2,409.59 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Musculoskeletal Transplant Foundation INC. | $1,220.15 | 2023-2025 | |
| Kci USA, INC. | $977.07 | 2019-2021 | |
| Urgo Medical North America, LLC | $641.70 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Mentor Worldwide LLC | $380.22 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $372.58 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Sientra, INC. | $124.10 | 2022 | |
| Polynovo North America LLC | $93.84 | 2024-2025 | Novosorb Btm |
| Polymedics Innovations INC. | $89.60 | 2023-2024 | |
| Smith+Nephew, INC. | $85.78 | 2021-2023 | Renasys Go V2 Home, Pico 7 |
| Davol INC. | $61.45 | 2023-2025 | Arista, Arista Ah Flexitip |
| Axogen | $60.76 | 2024 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $56.65 | 2023-2025 | Doc Band |
| Solventum Corporation | $45.43 | 2024-2025 | Promogran Prisma, Prevena Restor Bellaform, V.A.C.Instill |
| Avita Medical Americas, LLC | $43.27 | 2025 | Recell, Cohealyx, Permeaderm |
| Pacira Pharmaceuticals Incorporated | $39.87 | 2019-2025 | Exparel |
| Organogenesis INC. | $39.67 | 2024 | Puraply Am |
| Allergan, INC. | $38.72 | 2021-2022 | |
| Sanara Medtech INC. | $37.66 | 2020-2023 | Celleraterx |
| Next Science LLC | $30.74 | 2020-2021 | |
| Ovik Health, LLC | $28.69 | 2021 | |
| Medline Industries Lp | $27.37 | 2021 | |
| Hologic Sales and Service, LLC | $26.52 | 2023 | Coolseal Generator |
| Access Pro Medical, LLC | $24.87 | 2023 | Matriderm |
| Bioventus LLC | $22.71 | 2023 | Theragenesis Bilayer Wound Matrix |
| Rti Surgical, INC | $20.17 | 2023 | |
| Galderma Laboratories, L.P. | $13.20 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Dillingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.